Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparative Study of Guided Radiofrequency Ablation Using the CARTO® 3 and NavX™ Systems for the Treatment of Paroxysmal Atrial Fibrillation

NCT01036724 is registered in ClinicalTrials.gov with Biosense Webster, Inc. as lead sponsor.

NCT NCT01036724
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01036724 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparative Study of Guided Radiofrequency Ablation Using the CARTO® 3 and NavX™ Systems for the Treatment of Paroxysmal Atrial Fibrillation
Lead sponsor
Biosense Webster, Inc.
Phase
Observational
Overall status
Terminated
Start date
November 1, 2009
Completion date
August 25, 2010
Enrollment
107 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

paroxysmal atrial fibrillation